The Taizhou Medical High-tech Zone is forging ahead in the development of manufacturing pilot platforms.

Over 300 exhibitors presented their intelligent and technologically advanced products at the 15th China (Taizhou) International Medical Expo.

The 13th China Innovation and Entrepreneurship Competition for Biomedicine took place at China Medical City on Nov 19-21.

The Ustekinumab Injection treatment manufactured by Qyuns Therapeutics, located in the Taizhou Medical High-tech Zone, was approved for marketing.

Taizhou Port's new master plan – taking the key logistics facility in Taizhou city to the year 2035 – was recently approved.

Great Wall Motors' Taizhou branch has recently directed its attention towards the development of electric and smart vehicles.

Two products developed by Jiangsu Anbison Pharmaceutical, were approved by the National Medical Products Administration and passed consistency evaluations.

The Taizhou Port Economic Development Zone has been fostering economic growth by attracting high-end enterprises, expanding and upgrading existing businesses, and revitalizing underutilized assets.